Back to search results

Maestro 1.1 Post-Market Registry for Laparoscopic Surgery

This study is observing the real-life use of the Maestro Platform, a device that assists surgeons during laparoscopic surgery (a type of minimally invasive surgery using small incisions). Researchers want to see how safely and effectively the Maestro Platform is used in standard surgical procedures. They will be looking for any adverse events (unwanted side effects or complications) during and after surgery, and if the surgery can be completed using the Maestro Platform without needing to switch to a different surgical method due to a device issue. You may be able to join if you are an adult aged 18 to 100 years old and are scheduled for laparoscopic surgery. The current status of this study is unclear.

Study design
This is an observational study, meaning researchers will watch how the Maestro Platform is used in real-life surgical settings. It plans to enroll 600 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Adverse events and device-related complications will be monitored for 30 days after the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06103136

Maestro 1.1 Post-Market Registry

Recruiting
Not specifiedAges 18+Observational
Moon Surgical
~600 participants
Updated 2025-02-12 on ClinicalTrials.gov
What's tested:Laparoscopic surgery using the Maestro Platform

At a glance

Recruiting sites
12 of 12 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adverse Events (AEs) in terms of type (device/procedure related), seriousness, level of severity. Rate of occurence of intra-procedural and post-procedural adverse events, and device related complications
Measured over Adverse Events (AEs) in terms of type (device/procedure related), seriousness, level of severity. Rate of occurence of intra-procedural and post-procedural adverse events, and device related complications [ Time Frame: 30 days ]
+1 more outcome measured

Conditions

Surgery

Explore related trials

Surgical Procedure

Where it's being run

12 sites across 6 states
Florida4
France4
Colorado1
Texas1
Belgium1
Alpes Maritimes1

Who to contact

Anne Osdoit
[email protected]
6 60 42 28 31 · ext. +33
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participants will be adults aged ≥ 18 years scheduled for laparoscopic surgery.

Exclusion

Participants might be excluded based on the investigator's discretion.

What this trial measures

  • Adverse Events (AEs) in terms of type (device/procedure related), seriousness, level of severity. Rate of occurence of intra-procedural and post-procedural adverse events, and device related complicationsAdverse Events (AEs) in terms of type (device/procedure related), seriousness, level of severity. Rate of occurence of intra-procedural and post-procedural adverse events, and device related complications [ Time Frame: 30 days ]
  • Completion of the procedure using the Maestro Platform without conversion to a manual minimally invasive or open surgical procedure specifically due to a device failure or malfunctionDuring procedure